Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Gerber

Showing results (221-230 of 289) with videos related to

Pageof 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancerLecia V Sequist, Joachim von Pawel, Edward G Garmey, et al.
Contemporary Clinical Trials|September 12, 2022
Enhancing access to and diversity in cancer clinical trials through a financial reimbursement program: Protocol to evaluate a novel programDavid E Gerber, Jasmin A Tiro, Lorna H McNeill, et al.
Contemporary Clinical Trials Communications|April 16, 2024
Transferring care to enhance access to early-phase cancer clinical trials: Protocol to evaluate a novel programChika Nwachukwu, Sukh Makhnoon, Marieshia Person, et al.
Journal for Immunotherapy of Cancer|December 9, 2021
Humoral and cellular correlates of a novel immune-related adverse event and its treatmentAmrit S Gonugunta, Mitchell S von Itzstein, Hong Mu-Mosley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Development, Review, and Activation of Thoracic Oncology Investigator-Initiated TrialsDavid E Gerber, Claire R Wynters, Tanushree Prasad, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2025
Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical TrialYuanyuan Zhang, Aaron M Laine, Puneeth Iyengar, et al.
Head & Neck|February 14, 2019
Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profilingSaad A Khan, Bo Ci, Yang Xie, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2015
Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation TrialKenneth D Westover, Billy W Loo, David E Gerber, et al.
Neuro-Oncology|August 1, 2019
Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastomaGao Guo, Ke Gong, Vineshkumar Thidil Puliyappadamba, et al.
Clinical Chemistry and Laboratory Medicine|October 26, 2022
Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control studyAntigona Ulndreaj, Davor Brinc, Mehmet Altan, et al.
Pageof 29

Showing results (221-230 of 289) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancerLecia V Sequist, Joachim von Pawel, Edward G Garmey, et al.
Contemporary Clinical Trials|September 12, 2022
Enhancing access to and diversity in cancer clinical trials through a financial reimbursement program: Protocol to evaluate a novel programDavid E Gerber, Jasmin A Tiro, Lorna H McNeill, et al.
Contemporary Clinical Trials Communications|April 16, 2024
Transferring care to enhance access to early-phase cancer clinical trials: Protocol to evaluate a novel programChika Nwachukwu, Sukh Makhnoon, Marieshia Person, et al.
Journal for Immunotherapy of Cancer|December 9, 2021
Humoral and cellular correlates of a novel immune-related adverse event and its treatmentAmrit S Gonugunta, Mitchell S von Itzstein, Hong Mu-Mosley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Development, Review, and Activation of Thoracic Oncology Investigator-Initiated TrialsDavid E Gerber, Claire R Wynters, Tanushree Prasad, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2025
Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical TrialYuanyuan Zhang, Aaron M Laine, Puneeth Iyengar, et al.
Head & Neck|February 14, 2019
Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profilingSaad A Khan, Bo Ci, Yang Xie, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2015
Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation TrialKenneth D Westover, Billy W Loo, David E Gerber, et al.
Neuro-Oncology|August 1, 2019
Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastomaGao Guo, Ke Gong, Vineshkumar Thidil Puliyappadamba, et al.
Clinical Chemistry and Laboratory Medicine|October 26, 2022
Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control studyAntigona Ulndreaj, Davor Brinc, Mehmet Altan, et al.
Pageof 29